Research Article

Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients

Table 2

Summary of the regression analysis of the correlation between coronary stenosis and NAFLD.

Model 1Model 2
OR (95% CI)value for trendOR (95% CI)value for trend

NAFLD
 Grade 01(Reference)1(Reference)
 Grade 12.12(1.53–2.97)<0.001<0.0011.69(1.19–2.41)0.0040.013
 Grade 22.39(1.71–3.35)<0.0011.56(1.06–2.29)0.023
 Grade 34.04(2.23–8.11)<0.0012.25(1.05–4.80)0.037
Age (years)1.09(1.07–1.10)<0.0011.09(1.07–1.11)<0.001
Sex0.45(0.34–0.60)<0.0010.51(0.37–0.69)<0.001
BMI (kg/m2)1.00(0.95–1.05)0.960
HbA1c1.38(1.21–1.58)<0.001
TC (mg/dL)1.01(1.00–1.01)0.001
HDL (mg/dL)0.98(0.97–0.99)<0.001
SBP (mmHg)1.00(0.99–1.01)0.403
Hypertension2.05(1.48–2.85)<0.001
Smoking status1.79(1.24–2.60)0.002

NAFLD: nonalcoholic fatty liver disease; OR: odds ratio; CI: confidence interval; BMI: body mass index; TC: total cholesterol; HDL: high-density lipoprotein cholesterol; SBP: systolic blood pressure. Model 1 included age and sex. Model 2 included BMI, HbA1c, and Framingham risk factors (total cholesterol, HDL cholesterol, SBP, hypertension status, and smoking status) in addition to the variables addressed in Model 1.